Covidien Aneurysm Embolization Device Recall A Class I, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
FDA tagged Covidien’s April 1 recall of its Pipeline aneurysm embolization devices and Alligator retrieval devices as a high risk, class I action.